Top compounds associated with response to INTS12


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC -0.094 0.1
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.057 0.1
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.1
mRNA ELCPK CTRPv2 pan-cancer AAC 0.085 0.1
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.058 0.1
mRNA QL-XII-61 GDSC1000 pan-cancer AAC -0.087 0.1
mRNA silmitasertib CTRPv2 pan-cancer AAC 0.065 0.1
mRNA WH-4-023 GDSC1000 pan-cancer AAC -0.091 0.1
mRNA VAF-347 CTRPv2 pan-cancer AAC 0.078 0.1
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.1
Download CSV